Virtual Clinical Trials (VCTs), also called remote or decentralized trials, are a relatively new and yet underutilized method of conducting clinical research taking full advantage of technologies such as apps, electronic monitoring devices, and online social engagement platforms.
Virtual clinical trials (VCT) eliminate challenges posed by traditional clinical trials such as time-consuming procedures and delay in patient recruitment that has driven the demand for the virtual clinical trial market. Moreover, technological advancements in healthcare infrastructure and alliances between biotechnology, pharmaceutical & clinical research organization are anticipated to boost the virtual clinical trials market growth in the near future.
Market Analysis and Insights: Global Virtual Clinical Trials Market
The global Virtual Clinical Trials market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Virtual Clinical Trials market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Virtual Clinical Trials market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Virtual Clinical Trials market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Virtual Clinical Trials market.
Virtual Clinical Trials Breakdown Data by Type
Interventional Trials
Observational Trials
Expanded Access Trials
Virtual Clinical Trials Breakdown Data by Application
Oncology
Cardiovascular Disease
Others
Based on regional and country-level analysis, the Virtual Clinical Trials market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Virtual Clinical Trials market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The following players are covered in this report:
ICON Plc
LEO Innovation Lab
Science 37
PRA Health Sciences
Clinical Ink
Parexel
Medable
Oracle
CRF Health
Medidata
Covance
IQVIA
Virtual clinical trials (VCT) eliminate challenges posed by traditional clinical trials such as time-consuming procedures and delay in patient recruitment that has driven the demand for the virtual clinical trial market. Moreover, technological advancements in healthcare infrastructure and alliances between biotechnology, pharmaceutical & clinical research organization are anticipated to boost the virtual clinical trials market growth in the near future.
Market Analysis and Insights: Global Virtual Clinical Trials Market
The global Virtual Clinical Trials market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Virtual Clinical Trials market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Virtual Clinical Trials market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Virtual Clinical Trials market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Virtual Clinical Trials market.
Virtual Clinical Trials Breakdown Data by Type
Interventional Trials
Observational Trials
Expanded Access Trials
Virtual Clinical Trials Breakdown Data by Application
Oncology
Cardiovascular Disease
Others
Based on regional and country-level analysis, the Virtual Clinical Trials market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Virtual Clinical Trials market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The following players are covered in this report:
ICON Plc
LEO Innovation Lab
Science 37
PRA Health Sciences
Clinical Ink
Parexel
Medable
Oracle
CRF Health
Medidata
Covance
IQVIA
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Virtual Clinical Trials Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Interventional Trials
1.2.3 Observational Trials
1.2.4 Expanded Access Trials
1.3 Market by Application
1.3.1 Global Virtual Clinical Trials Market Share by Application: 2020 VS 2026
1.3.2 Oncology
1.3.3 Cardiovascular Disease
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Virtual Clinical Trials Market Perspective (2015-2026)
2.2 Global Virtual Clinical Trials Growth Trends by Regions
2.2.1 Virtual Clinical Trials Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Virtual Clinical Trials Historic Market Share by Regions (2015-2020)
2.2.3 Virtual Clinical Trials Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Virtual Clinical Trials Players by Market Size
3.1.1 Global Top Virtual Clinical Trials Players by Revenue (2015-2020)
3.1.2 Global Virtual Clinical Trials Revenue Market Share by Players (2015-2020)
3.2 Global Virtual Clinical Trials Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Virtual Clinical Trials Revenue
3.4 Global Virtual Clinical Trials Market Concentration Ratio
3.4.1 Global Virtual Clinical Trials Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Virtual Clinical Trials Revenue in 2019
3.5 Key Players Virtual Clinical Trials Area Served
3.6 Key Players Virtual Clinical Trials Product Solution and Service
3.7 Date of Enter into Virtual Clinical Trials Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Virtual Clinical Trials Breakdown Data by Type (2015-2026)
4.1 Global Virtual Clinical Trials Historic Market Size by Type (2015-2020)
4.2 Global Virtual Clinical Trials Forecasted Market Size by Type (2021-2026)
5 Virtual Clinical Trials Breakdown Data by Application (2015-2026)
5.1 Global Virtual Clinical Trials Historic Market Size by Application (2015-2020)
5.2 Global Virtual Clinical Trials Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Virtual Clinical Trials Market Size (2015-2026)
6.2 North America Virtual Clinical Trials Market Size by Type (2015-2020)
6.3 North America Virtual Clinical Trials Market Size by Application (2015-2020)
6.4 North America Virtual Clinical Trials Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Virtual Clinical Trials Market Size (2015-2026)
7.2 Europe Virtual Clinical Trials Market Size by Type (2015-2020)
7.3 Europe Virtual Clinical Trials Market Size by Application (2015-2020)
7.4 Europe Virtual Clinical Trials Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Virtual Clinical Trials Market Size (2015-2026)
8.2 China Virtual Clinical Trials Market Size by Type (2015-2020)
8.3 China Virtual Clinical Trials Market Size by Application (2015-2020)
8.4 China Virtual Clinical Trials Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Virtual Clinical Trials Market Size (2015-2026)
9.2 Japan Virtual Clinical Trials Market Size by Type (2015-2020)
9.3 Japan Virtual Clinical Trials Market Size by Application (2015-2020)
9.4 Japan Virtual Clinical Trials Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Virtual Clinical Trials Market Size (2015-2026)
10.2 Southeast Asia Virtual Clinical Trials Market Size by Type (2015-2020)
10.3 Southeast Asia Virtual Clinical Trials Market Size by Application (2015-2020)
10.4 Southeast Asia Virtual Clinical Trials Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11Key Players Profiles
11.1 ICON Plc
11.1.1 ICON Plc Company Details
11.1.2 ICON Plc Business Overview
11.1.3 ICON Plc Virtual Clinical Trials Introduction
11.1.4 ICON Plc Revenue in Virtual Clinical Trials Business (2015-2020))
11.1.5 ICON Plc Recent Development
11.2 LEO Innovation Lab
11.2.1 LEO Innovation Lab Company Details
11.2.2 LEO Innovation Lab Business Overview
11.2.3 LEO Innovation Lab Virtual Clinical Trials Introduction
11.2.4 LEO Innovation Lab Revenue in Virtual Clinical Trials Business (2015-2020)
11.2.5 LEO Innovation Lab Recent Development
11.3 Science 37
11.3.1 Science 37 Company Details
11.3.2 Science 37 Business Overview
11.3.3 Science 37 Virtual Clinical Trials Introduction
11.3.4 Science 37 Revenue in Virtual Clinical Trials Business (2015-2020)
11.3.5 Science 37 Recent Development
11.4 PRA Health Sciences
11.4.1 PRA Health Sciences Company Details
11.4.2 PRA Health Sciences Business Overview
11.4.3 PRA Health Sciences Virtual Clinical Trials Introduction
11.4.4 PRA Health Sciences Revenue in Virtual Clinical Trials Business (2015-2020)
11.4.5 PRA Health Sciences Recent Development
11.5 Clinical Ink
11.5.1 Clinical Ink Company Details
11.5.2 Clinical Ink Business Overview
11.5.3 Clinical Ink Virtual Clinical Trials Introduction
11.5.4 Clinical Ink Revenue in Virtual Clinical Trials Business (2015-2020)
11.5.5 Clinical Ink Recent Development
11.6 Parexel
11.6.1 Parexel Company Details
11.6.2 Parexel Business Overview
11.6.3 Parexel Virtual Clinical Trials Introduction
11.6.4 Parexel Revenue in Virtual Clinical Trials Business (2015-2020)
11.6.5 Parexel Recent Development
11.7 Medable
11.7.1 Medable Company Details
11.7.2 Medable Business Overview
11.7.3 Medable Virtual Clinical Trials Introduction
11.7.4 Medable Revenue in Virtual Clinical Trials Business (2015-2020)
11.7.5 Medable Recent Development
11.8 Oracle
11.8.1 Oracle Company Details
11.8.2 Oracle Business Overview
11.8.3 Oracle Virtual Clinical Trials Introduction
11.8.4 Oracle Revenue in Virtual Clinical Trials Business (2015-2020)
11.8.5 Oracle Recent Development
11.9 CRF Health
11.9.1 CRF Health Company Details
11.9.2 CRF Health Business Overview
11.9.3 CRF Health Virtual Clinical Trials Introduction
11.9.4 CRF Health Revenue in Virtual Clinical Trials Business (2015-2020)
11.9.5 CRF Health Recent Development
11.10 Medidata
11.10.1 Medidata Company Details
11.10.2 Medidata Business Overview
11.10.3 Medidata Virtual Clinical Trials Introduction
11.10.4 Medidata Revenue in Virtual Clinical Trials Business (2015-2020)
11.10.5 Medidata Recent Development
11.11 Covance
10.11.1 Covance Company Details
10.11.2 Covance Business Overview
10.11.3 Covance Virtual Clinical Trials Introduction
10.11.4 Covance Revenue in Virtual Clinical Trials Business (2015-2020)
10.11.5 Covance Recent Development
11.12 IQVIA
10.12.1 IQVIA Company Details
10.12.2 IQVIA Business Overview
10.12.3 IQVIA Virtual Clinical Trials Introduction
10.12.4 IQVIA Revenue in Virtual Clinical Trials Business (2015-2020)
10.12.5 IQVIA Recent Development
12Analyst's Viewpoints/Conclusions
13Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Virtual Clinical Trials Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Interventional Trials
1.2.3 Observational Trials
1.2.4 Expanded Access Trials
1.3 Market by Application
1.3.1 Global Virtual Clinical Trials Market Share by Application: 2020 VS 2026
1.3.2 Oncology
1.3.3 Cardiovascular Disease
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Virtual Clinical Trials Market Perspective (2015-2026)
2.2 Global Virtual Clinical Trials Growth Trends by Regions
2.2.1 Virtual Clinical Trials Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Virtual Clinical Trials Historic Market Share by Regions (2015-2020)
2.2.3 Virtual Clinical Trials Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Virtual Clinical Trials Players by Market Size
3.1.1 Global Top Virtual Clinical Trials Players by Revenue (2015-2020)
3.1.2 Global Virtual Clinical Trials Revenue Market Share by Players (2015-2020)
3.2 Global Virtual Clinical Trials Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Virtual Clinical Trials Revenue
3.4 Global Virtual Clinical Trials Market Concentration Ratio
3.4.1 Global Virtual Clinical Trials Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Virtual Clinical Trials Revenue in 2019
3.5 Key Players Virtual Clinical Trials Area Served
3.6 Key Players Virtual Clinical Trials Product Solution and Service
3.7 Date of Enter into Virtual Clinical Trials Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Virtual Clinical Trials Breakdown Data by Type (2015-2026)
4.1 Global Virtual Clinical Trials Historic Market Size by Type (2015-2020)
4.2 Global Virtual Clinical Trials Forecasted Market Size by Type (2021-2026)
5 Virtual Clinical Trials Breakdown Data by Application (2015-2026)
5.1 Global Virtual Clinical Trials Historic Market Size by Application (2015-2020)
5.2 Global Virtual Clinical Trials Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Virtual Clinical Trials Market Size (2015-2026)
6.2 North America Virtual Clinical Trials Market Size by Type (2015-2020)
6.3 North America Virtual Clinical Trials Market Size by Application (2015-2020)
6.4 North America Virtual Clinical Trials Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Virtual Clinical Trials Market Size (2015-2026)
7.2 Europe Virtual Clinical Trials Market Size by Type (2015-2020)
7.3 Europe Virtual Clinical Trials Market Size by Application (2015-2020)
7.4 Europe Virtual Clinical Trials Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Virtual Clinical Trials Market Size (2015-2026)
8.2 China Virtual Clinical Trials Market Size by Type (2015-2020)
8.3 China Virtual Clinical Trials Market Size by Application (2015-2020)
8.4 China Virtual Clinical Trials Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Virtual Clinical Trials Market Size (2015-2026)
9.2 Japan Virtual Clinical Trials Market Size by Type (2015-2020)
9.3 Japan Virtual Clinical Trials Market Size by Application (2015-2020)
9.4 Japan Virtual Clinical Trials Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Virtual Clinical Trials Market Size (2015-2026)
10.2 Southeast Asia Virtual Clinical Trials Market Size by Type (2015-2020)
10.3 Southeast Asia Virtual Clinical Trials Market Size by Application (2015-2020)
10.4 Southeast Asia Virtual Clinical Trials Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11Key Players Profiles
11.1 ICON Plc
11.1.1 ICON Plc Company Details
11.1.2 ICON Plc Business Overview
11.1.3 ICON Plc Virtual Clinical Trials Introduction
11.1.4 ICON Plc Revenue in Virtual Clinical Trials Business (2015-2020))
11.1.5 ICON Plc Recent Development
11.2 LEO Innovation Lab
11.2.1 LEO Innovation Lab Company Details
11.2.2 LEO Innovation Lab Business Overview
11.2.3 LEO Innovation Lab Virtual Clinical Trials Introduction
11.2.4 LEO Innovation Lab Revenue in Virtual Clinical Trials Business (2015-2020)
11.2.5 LEO Innovation Lab Recent Development
11.3 Science 37
11.3.1 Science 37 Company Details
11.3.2 Science 37 Business Overview
11.3.3 Science 37 Virtual Clinical Trials Introduction
11.3.4 Science 37 Revenue in Virtual Clinical Trials Business (2015-2020)
11.3.5 Science 37 Recent Development
11.4 PRA Health Sciences
11.4.1 PRA Health Sciences Company Details
11.4.2 PRA Health Sciences Business Overview
11.4.3 PRA Health Sciences Virtual Clinical Trials Introduction
11.4.4 PRA Health Sciences Revenue in Virtual Clinical Trials Business (2015-2020)
11.4.5 PRA Health Sciences Recent Development
11.5 Clinical Ink
11.5.1 Clinical Ink Company Details
11.5.2 Clinical Ink Business Overview
11.5.3 Clinical Ink Virtual Clinical Trials Introduction
11.5.4 Clinical Ink Revenue in Virtual Clinical Trials Business (2015-2020)
11.5.5 Clinical Ink Recent Development
11.6 Parexel
11.6.1 Parexel Company Details
11.6.2 Parexel Business Overview
11.6.3 Parexel Virtual Clinical Trials Introduction
11.6.4 Parexel Revenue in Virtual Clinical Trials Business (2015-2020)
11.6.5 Parexel Recent Development
11.7 Medable
11.7.1 Medable Company Details
11.7.2 Medable Business Overview
11.7.3 Medable Virtual Clinical Trials Introduction
11.7.4 Medable Revenue in Virtual Clinical Trials Business (2015-2020)
11.7.5 Medable Recent Development
11.8 Oracle
11.8.1 Oracle Company Details
11.8.2 Oracle Business Overview
11.8.3 Oracle Virtual Clinical Trials Introduction
11.8.4 Oracle Revenue in Virtual Clinical Trials Business (2015-2020)
11.8.5 Oracle Recent Development
11.9 CRF Health
11.9.1 CRF Health Company Details
11.9.2 CRF Health Business Overview
11.9.3 CRF Health Virtual Clinical Trials Introduction
11.9.4 CRF Health Revenue in Virtual Clinical Trials Business (2015-2020)
11.9.5 CRF Health Recent Development
11.10 Medidata
11.10.1 Medidata Company Details
11.10.2 Medidata Business Overview
11.10.3 Medidata Virtual Clinical Trials Introduction
11.10.4 Medidata Revenue in Virtual Clinical Trials Business (2015-2020)
11.10.5 Medidata Recent Development
11.11 Covance
10.11.1 Covance Company Details
10.11.2 Covance Business Overview
10.11.3 Covance Virtual Clinical Trials Introduction
10.11.4 Covance Revenue in Virtual Clinical Trials Business (2015-2020)
10.11.5 Covance Recent Development
11.12 IQVIA
10.12.1 IQVIA Company Details
10.12.2 IQVIA Business Overview
10.12.3 IQVIA Virtual Clinical Trials Introduction
10.12.4 IQVIA Revenue in Virtual Clinical Trials Business (2015-2020)
10.12.5 IQVIA Recent Development
12Analyst's Viewpoints/Conclusions
13Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
